KVUE - Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health.

As of Nov 13, 2026: spot at $21.98, ATM IV 76.2%, max pain $19.00, GEX (assumed dealer book) $143.3K of delta per 1% move.

Exposures are the assumed dealer book over the expirations within 30 days of the session, or the first four when none are (4 expirations, through Dec 11, 2026), as of Nov 13, 2026. Assumes dealers are long the calls and short the puts, a share p of open interest each - here 100% of open interest (the GEX page sets the share). A date without a stored exposure is a gap; a value marked * is partial, averaged over fewer days, or may include contracts expiring that day or of an unreadable expiration: its reason is printed beside it.

Sector
Consumer Defensive
Industry
Household & Personal Products
Market Cap
$37.09B
P/E Ratio
21.95
Beta
0.45
52-Week Range
15.94-20.13
Dividend Yield
$0.83
CEO
Kirk L. Perry
Employees
21,890
IPO Date
May 4, 2023
Exchange
NYSE

What KVUE Looks Like to Options Traders Today

IV rank of 85.3% signals elevated pricing relative to the 1-year history, conditions that typically favor premium-selling structures (credit spreads, iron condors, covered calls); the assumed dealer book's GEX is positive ($143.3K of delta per 1% move): its hedging leans against the trend, damping realized volatility where real dealers are positioned like the book; the 25-delta skew (-0.120) prices puts richer than calls, the typical equity downside-protection skew.

What This Page Covers

The KVUE overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.